Prescription medicine

Dextrose, magnesium chloride and 4 other ingredients

Dextrose, magnesium chloride and 4 other ingredients is a prescription medicine. No generic is listed in FDA's NDC Directory.

No generic listed

Check it at the source: the dextrose, magnesium chloride and 4 other ingredients FDA label on DailyMed (effective October 30, 2025); every dextrose, magnesium chloride and 4 other ingredients label on DailyMed.

Highlights of the record

FDA label of October 30, 2025; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026

Used for

From the label: indications and usage
Ionosol MB and 5% Dextrose Injection is indicated for intravenous administration to infants for treatment of dehydration, acidosis, diarrhea, and burns, but only after administration of an initial priming solution: 15 mL of 5% dextrose and 0.45% Sodium Chloride Injection/kg of body weight.

Forms and strengths

5 g/100ml / 260 mg/100ml / 141 mg/100ml / 30 mg/100ml / 15 mg/100ml / 25 mg/100ml

Injection (solution).

On the market

Generic approvals: No generic approved
Labelers listed (NDC): 1 of which 0 under generic applications, 1 under brand applications, repackagers included

Supply and safety

Pharmacy cost (NADAC): Not in the survey
Shortage (FDA): No current entry
Recalls by its makers (FDA): No recall recorded
FAERS reports: 1 through July 30, 2026

What is dextrose, magnesium chloride and 4 other ingredients used for?

From the label: indications and usage
Ionosol MB and 5% Dextrose Injection is indicated for intravenous administration to infants for treatment of dehydration, acidosis, diarrhea, and burns, but only after administration of an initial priming solution: 15 mL of 5% dextrose and 0.45% Sodium Chloride Injection/kg of body weight. In adults, Ionosol MB and 5% Dextrose Injection is indicated postoperatively for intravenous fluid and electrolyte maintenance therapy, with a small amount of carbohydrate calories for reducing catabolism of endogenous protein reserves.

Conditions named in the indications of dextrose, magnesium chloride and 4 other ingredients's FDA labels, with every medicine labeled for each:

Diarrhea

From other dextrose, magnesium chloride and 4 other ingredients labels
Diarrhea: INDICATIONS AND USAGE Ionosol MB and 5% Dextrose Injection is indicated for intravenous administration to infants for treatment of dehydration, acidosis, diarrhea, and burns, but only after administration of an initial priming solution:

FDA pharmacologic class: Calculi Dissolution Agent, Osmotic Laxative and Potassium Salt.

Source: FDA drug label (Ionosol MB and Dextrose), ICU Medical Inc., effective October 30, 2025 (SPL set 1b457b1d-0e80-4578-ba6f-dedf513fc962), via openFDA; the full label on DailyMed

Is there a generic for dextrose, magnesium chloride and 4 other ingredients?

No generic dextrose, magnesium chloride and 4 other ingredients is approved (Drugs@FDA, October 8, 2026).

Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)

What do FAERS reports show for dextrose, magnesium chloride and 4 other ingredients?

The FDA Adverse Event Reporting System holds 1 report that list dextrose, magnesium chloride and 4 other ingredients among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 0 are coded as a death and 0 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.

The most reported reactions

Expired Product Administered (a use or a product term, not a reaction)1
No Adverse Event (a use or a product term, not a reaction)1

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026

What else is labeled for the same conditions as dextrose, magnesium chloride and 4 other ingredients?

2 other medicines are given the same way (intravenous) and in the same FDA class as dextrose, magnesium chloride and 4 other ingredients or labeled mainly for the same use (diarrhea), the same class first. Diarrhea lists all 16 medicines labeled for it, by any route. They are listed as records, not as substitutes: whether one can replace another is a prescriber's decision.

Medicine	Shared indication	Generic labelers (intravenous)	Pharmacy cost	Shortage
Sodium bicarbonate	Diarrhea	22 labelers	$0.154 per mL 8.4% vial	In shortage
Octreotide	Diarrhea	8 labelers	$2.53 per mL 100 mcg/mL vial	No current entry

Source: FDA drug labels (indications), NDC Directory, NADAC of October 7, 2026, FDA shortages (October 8, 2026)

What next?

Other calculi dissolution agents: the pharmacologic class, with prices and generics
Dextrose, magnesium chloride and 4 other ingredients side effects: the label's list beside FAERS reports
Check an interaction: what two or more labels say about each other